Voriconazole versus isavuconazole for invasive aspergillosis: a retrospective analysis in a medically insured U.S. population (2017–2020)

Sophea Chan, Laura Leigh Stoudenmire, Xianyan Chen, Duna Zhan, Andrés F. Henao-Martínez, Daniel B. Chastain

Open source

DOI
10.1177/20499361251347778
Published
2025-06-27
Container
Therapeutic Advances in Infectious Disease
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/20499361251347778,
  title = {Voriconazole versus isavuconazole for invasive aspergillosis: a retrospective analysis in a medically insured U.S. population (2017–2020)},
  author = {Sophea Chan and Laura Leigh Stoudenmire and Xianyan Chen and Duna Zhan and Andrés F. Henao-Martínez and Daniel B. Chastain},
  year = {2025},
  journal = {Therapeutic Advances in Infectious Disease},
  doi = {10.1177/20499361251347778},
  url = {https://doi.org/10.1177/20499361251347778}
}

RIS

TY  - JOUR
TI  - Voriconazole versus isavuconazole for invasive aspergillosis: a retrospective analysis in a medically insured U.S. population (2017–2020)
AU  - Sophea Chan
AU  - Laura Leigh Stoudenmire
AU  - Xianyan Chen
AU  - Duna Zhan
AU  - Andrés F. Henao-Martínez
AU  - Daniel B. Chastain
PY  - 2025
JO  - Therapeutic Advances in Infectious Disease
DO  - 10.1177/20499361251347778
UR  - https://doi.org/10.1177/20499361251347778
ER  - 

APA

Chan, S., Stoudenmire, L. L., Chen, X., Zhan, D., Henao-Martínez, A. F., & Chastain, D. B. (2025). Voriconazole versus isavuconazole for invasive aspergillosis: a retrospective analysis in a medically insured U.S. population (2017–2020). Therapeutic Advances in Infectious Disease. https://doi.org/10.1177/20499361251347778

Source records